Global Cell Culture Media Market Poised for Steady Growth: Reaching US$6.7 Billion by 2034 at a CAGR of 6.66%

Global Cell Culture Media Market
Global Cell Culture Media Market

The global cell culture media market is expected to have steady growth and, by 2034, be valued at an estimated US$6,699.93 million. From a market value of US$3,513.8 million in 2024, this amounts to a Compound Annual Growth Rate (CAGR) of 6.66% during the forecast period.

Navigate Future Trends With a Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14366

Multiple Drivers Fueling Market Expansion

Several key factors are propelling the cell culture media market forward:

  • Rising Biopharmaceutical Demand: One of the main factors driving the expansion of cell culture media is the increasing need for biopharmaceuticals, such as protein therapies and vaccines. The research and manufacturing of these life-saving medications depend on these solutions.
  • Cell-Based Therapies Gain Traction: Market expansion is being driven by the growing use of cell-based therapies in a range of medical applications. Cell culture medium is essential to the creation and growth of these cutting-edge therapeutic alternatives.
  • Drug Discovery Advancements: The market gains from cell culture media’s increasing significance in drug discovery. For the successful investigation and creation of novel drugs, precisely regulated cell conditions are essential.
  • Government and Research Funding: Increased government support and research funding allocated to biotechnology and life sciences sectors are significant contributors to market growth. This financial backing fosters innovation and propels the development of new applications for cell culture media.
  • Global Biotechnology Boom: The global expansion of biotechnology industries is another factor driving market growth. As companies explore novel avenues and applications for cell culture media, demand is expected to continue rising.
  • Technological Advancements: Ongoing advancements in cell culture media formulations and technologies are a key growth driver. These advancements lead to the creation of improved and specialized solutions catering to specific needs within cell-based research.
  • Personalized Medicine Focus: The growing awareness and adoption of personalized medicine approaches are propelling the use of cell culture media. This field relies on tailored treatments based on individual patient characteristics, requiring specialized cell culture techniques.

Learn How We Conduct Research:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14366

Competitive Landscape:

Important companies like Avantor, Inc., Thermo Fisher Scientific, Inc., Caisson Laboratories Inc., Becton Dickinson and Company, Lonza Group AG, Bio-Rad Laboratories, Inc., General Electric Company, etc. are present in the worldwide cell culture media market.

Many businesses are making significant investments in R&D to develop novel and specialized formulations of cell culture medium. The aforementioned tasks involve creating specified and serum-free media, refining current formulations, and integrating cutting-edge technology to fulfill the dynamic requirements of biopharmaceutical and life sciences research.

Recent Developments

  • On July 12, 2023, Merck announced the expansion of its Lenexa, Kansas facility, making it the company’s largest dry powder cell culture media facility and Center of Excellence in North America.
  • In October 2023, London-based startup Multus Biotechnology focused on cutting the cost of cell culture media for cultivated meat by leveraging AI to optimize formulation efficiency. The startup addresses challenges in ingredient quality, scalability, and bioprocess productivity, aiming to enhance the sustainability and cost-effectiveness of cell culture media.
  • On July 27, 2023, MilliporeSigma invested $25 million to expand its cell culture media production facility in Lenexa, Kansas. The expansion included 98,000 ft2 of lab space, reinforcing the company’s commitment to meeting the increasing demand for cell culture media. Lenexa now serves as one of the three global centers of excellence for dry powder cell culture media manufacturing.

Key Companies in the Market:

  • Avantor, Inc.
  • Thermo Fisher Scientific, Inc.
  • Caisson Laboratories Inc.
  • Becton Dickinson and Company
  • Lonza Group AG
  • Bio-Rad Laboratories, Inc.
  • General Electric Company
  • Cell Culture Technologies LLC
  • Corning Incorporated
  • Fujifilm Holdings Corporation
  • Hi Media Laboratories Pvt. Ltd.
  • Merck & Co., Inc.

Market Segmentation:

By Type:

  • Serum-free Media
  • CHO Media
  • HEK 293 Media
  • BHK Media
  • VERO Cell Media
    • Insect Cell Media
    • Serum-free Stem Cell Media
    • CAR T-cell Media
    • Other Serum-free Media
    • Classical Media & Salts
    • Stem Cell Culture Media
    • Specialty Media
    • Chemically defined Media
    • Other Cell Culture Media

By Application:

  • Biopharmaceutical Production
  • Monoclonal antibodies
  • Cancer Research
  • Vaccines production
  • Other therapeutic proteins
  • Diagnostics
  • Drug Screening & Development
  • Tissue Engineering & Regenerative Medicine
  • Cell and gene therapy
  • Other tissue engineering & regenerative medicine applications
  • Other Application

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Explore Comprehensive Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/14366

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *